Study guide
13.3 Interpreting & Conveying Interrogated Data: Diagnostics, Counters & Stored Episodes
Registered Cardiac Electrophysiology Specialist RCES
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Pre-Procedural Assessment & Patient Preparation
1.1 Procedure Room Preparation, Equipment Verification & Aseptic Readiness 1.2 Pre-Procedural Clinical Evaluation, Labs, Consents & The Universal Time-Out 1.3 Patient Identification, Transport, HIPAA & Procedural Documentation 1.4 Patient Monitoring Setup, Defibrillator Pads & Pre-Procedural CIED Interrogation 1.5 Vascular Access Planning, Skin Preparation & Sterile Draping
2 Chapter 2: Cardiac Anatomy, Conduction & Electrophysiologic Foundations
2.1 Cardiac Anatomy for the EP Lab: Chambers, Access Routes & Coronary Supply 2.2 The Cardiac Conduction System, Action Potentials & Ion Channel Physiology 2.3 Cardiac Vector Analysis, 12-Lead ECG Fundamentals & Axis Determination
3 Chapter 3: EP Lab Instrumentation, Connectology & Lab Safety
3.1 EP Recording System Architecture, Signal Amplification & Frequency Filters 3.2 Cardiac Stimulator Operation, Junction Box Routing & Noise Troubleshooting 3.3 Electrical Safety, Electrical Units, Electrocautery & Fire Safety 3.4 Radiation Safety Physics, ALARA Principles, Shielding & Dose Limits 3.5 Procedural Supplies, Catheter Inventory, Surgical Instrumentation & Wound Closure
4 Chapter 4: Intra-Procedural Imaging, Sedation & Physiologic Monitoring
4.1 Fluoroscopic Projections (RAO, LAO, AP) & X-ray Tube Optimization 4.2 Intracardiac Echocardiography (ICE) Principles, Views & Catheter Navigation 4.3 Non-Radiographic Imaging: Cardiac CT/MRI, Image Fusion & Ultrasound-Guided Access 4.4 Conscious Sedation Protocols, Airway Management & Hemodynamic Monitoring 4.5 Vital Signs, Normal Laboratory Values & Intra-Procedural Lab Monitoring
5 Chapter 5: EP Pharmacology, Anticoagulation & Emergency Drugs
5.1 Vaughan Williams Antiarrhythmic Classification & EP Electrophysiology 5.2 Diagnostic & Provocative Drugs: Adenosine, Isoproterenol, Epinephrine, Atropine 5.3 Sedation & Analgesia Pharmacology, Reversal Agents & Recovery Scoring 5.4 Heparin Protocol, ACT Monitoring & Emergency Reversal with Protamine 5.5 Oral Anticoagulants, Antiplatelets & Peri-Procedural Management 5.6 ACLS Algorithms & Emergency Medications in the EP Lab
6 Chapter 6: Catheter Navigation, Normal Electrograms & Baseline Intervals
6.1 Standard Diagnostic Catheter Positions & Fluoroscopic/Anatomical Landmarks 6.2 Intracardiac Electrogram Interpretation & Normal Baseline Intervals (PA, AH, HV) 6.3 His Bundle Electrogram Recording, Split His Potentials & Infranodal Conduction
7 Chapter 7: Programmed Electrical Stimulation & Refractory Periods
7.1 Pacing Stimulation Fundamentals, Capture Thresholds & Drive Trains 7.2 Refractory Period Determination (ERP, RRP, FRP) & Sinus Node Function Testing (SNRT, cSNRT) 7.3 AV Nodal Decremental Conduction & Dual AV Nodal Physiology
8 Chapter 8: Diagnostic Evaluation of Supraventricular & Ventricular Tachycardias
8.1 Narrow-Complex Tachycardias: Differential Diagnosis of AVNRT, AVRT & AT 8.2 Diagnostic Pacing Maneuvers: Entrainment, PPI-TCL, V-A-V vs V-A-A-V & His-Refractory PVCs 8.3 Wide-Complex Tachycardias & Ventricular Arrhythmia Mapping Criteria
9 Chapter 9: Bradyarrhythmias, AV Block & Atrial Arrhythmia Recognition
9.1 Bradyarrhythmias, AV Block Classification & Conduction System Disease 9.2 Atrial Fibrillation & Atrial Flutter: Classification, ECG Recognition & Stroke Risk
10 Chapter 10: 3D Electroanatomic Mapping & Ablation Biophysics
10.1 3D Electroanatomic Mapping Systems (Carto, EnSite, Rhythmia) Setup & Troubleshooting 10.2 Activation, Propagation & Bipolar Voltage Substrate Mapping 10.3 Ablation Biophysics: Radiofrequency, Cryoablation & Pulsed Field Ablation (PFA)
11 Chapter 11: Transseptal Access, Catheter Ablation Targets & Endpoints
11.1 Transseptal Puncture: Anatomy, Technique, Imaging Guidance & Complications 11.2 Catheter Ablation of AVNRT Slow Pathway & Accessory Pathways (WPW) 11.3 Cavotricuspid Isthmus (CTI) Ablation for Typical Atrial Flutter 11.4 Pulmonary Vein Isolation (PVI) for AFib & Ventricular Tachycardia Ablation
12 Chapter 12: Cardiac Implantable Electronic Devices: Implantation & Testing
12.1 Pacemaker & Transvenous ICD Implantation Techniques & Safety 12.2 Intra-Procedural Electrical Testing: Sensing, Pacing Thresholds, Impedance & DFT 12.3 Cardiac Resynchronization Therapy (CRT) & Conduction System Pacing (HBP, LBBAP)
13 Chapter 13: CIED Interrogation, Programming & Troubleshooting
13.1 NBG Pacemaker Codes, Pacing Modes & Timing Cycles 13.2 CIED Interrogation Workflow, Programmer Operation & Peri-Procedural Reprogramming 13.3 Interpreting & Conveying Interrogated Data: Diagnostics, Counters & Stored Episodes 13.4 Pacing & Sensing Malfunctions, Electromagnetic Interference & Temporary Pacing
14 Chapter 14: Specialized Devices, Extraction & Acute Procedural Emergencies
14.1 Subcutaneous ICD (S-ICD), Leadless Pacemakers & Left Atrial Appendage Closure 14.2 Transvenous Lead Extraction Tools, Techniques & Safety Precautions 14.3 Acute Procedural Emergencies: Perforation, Tamponade, Pericardiocentesis & Air Embolism
15 Chapter 15: Post-Procedural Care, Hemostasis & Complication Management
15.1 Femoral Hemostasis Techniques: Manual Compression, Figure-of-8 & Closure Devices 15.2 Post-Procedural Complications: Vascular Injury, AV Block, Esophageal Injury & Neurologic Deficits 15.3 Post-Procedural CIED Assessment, Device Follow-Up & Wound Care 15.4 Post-Procedure Patient Recovery, Discharge Education & Clinical Handover
13.3 Interpreting & Conveying Interrogated Data: Diagnostics, Counters & Stored Episodes
Key Takeaways Explain This Topic AI
Task B7 is separate from task B6: the specialist must interpret interrogated data and convey it accurately to the operator, not merely retrieve it.
Marker channels annotate the device's own interpretation, so a marker that disagrees with the electrogram identifies a sensing problem rather than an arrhythmia.
Atrial high-rate episodes lasting 24 hours or more carry meaningfully elevated stroke risk and should be reported explicitly with their burden.
Right ventricular pacing above roughly 40 percent is associated with pacing-induced cardiomyopathy and heart failure hospitalization.
A CRT device delivering less than about 90-95 percent biventricular pacing is under-delivering therapy, and the cause must be identified.
Last updated: September 2026
13.3 Interpreting & Conveying Interrogated Data: Diagnostics, Counters & Stored Episodes
CCI splits device work into two consecutive intra-procedural tasks: B6 — Interrogate CIEDs and B7 — Interpret and convey interrogated data from CIEDs . The separation is deliberate. Pulling a report is mechanical; reading it correctly and telling the operator what matters, in the middle of a case, is the skill.
1. Reading a Stored Episode
Every stored episode has three synchronized layers, and interpretation means reading them together.
Layer What it is
Electrogram (EGM) The actual recorded signal — near-field (bipolar tip-to-ring, local myocardium), far-field (shock coil to can, a wide "surface-like" view), or atrial
Marker channel The device's annotation of what it thought each signal was: AS/AP (atrial sensed/paced), VS/VP, TS/TF (tachy sensed/fibrillation), and therapy markers
Interval plot Measured cycle lengths, plotted against the programmed detection zones
The single most useful diagnostic principle: when the marker channel disagrees with the electrogram , the problem is sensing , not rhythm. If the ventricular electrogram shows a regular sinus rhythm at 80 bpm while the markers show alternating VS-VS pairs at intervals implying 160 bpm, the device is double-counting — not observing a tachycardia.
Near-field versus far-field electrograms
Near-field (bipolar) shows sharp, local, high-frequency signals and is used for timing and rate .
Far-field (can-to-coil) produces a broad, surface-ECG-like tracing and is used for morphology — including QRS width and the morphology-discrimination algorithms that separate SVT from VT.
Reading both together answers the discrimination question: a wide, distorted far-field morphology different from the stored sinus template supports VT, while a preserved sinus morphology at a fast rate supports SVT with a rapid conducted response.
2. Counters and Diagnostics
- Diagnostic Interpretation
- Percentage atrial paced High values suggest sinus node dysfunction or an aggressively programmed lower rate
Percentage ventricular paced > ~40% RV pacing is associated with pacing-induced cardiomyopathy and heart failure hospitalization
Percentage biventricular paced (CRT) Target ≥ 95% ; below ~90% the patient is under-treated
Rate histogram Distribution of heart rates; a histogram crowded at the lower rate limit suggests chronotropic incompetence or an over-aggressive lower rate
- Mode switch episodes Count and total duration = atrial fibrillation burden
- Atrial high-rate episodes (AHRE) Device-detected atrial tachyarrhythmia, often subclinical
- Sensor / activity trend Patient activity over time; a falling trend can precede heart failure decompensation
- Thoracic impedance Falls as pulmonary fluid accumulates; used in heart failure alerts
- Non-sustained VT episodes Count and cycle length; may precede clinical events
- Atrial high-rate episodes
Device-detected AHRE are frequently the first evidence of atrial fibrillation in a patient with no symptoms, and their duration is what matters:
Episodes lasting ≥ 24 hours are associated with a meaningfully increased stroke risk and generally prompt consideration of anticoagulation in a patient with elevated CHA₂DS₂-VASc.
Very brief episodes (< 5-6 minutes) carry much lower risk, and the evidence for anticoagulating them is weak.
Every AHRE must be confirmed on the electrogram , because far-field R-wave oversensing, atrial lead noise, and repetitive non-reentrant ventriculoatrial synchrony all masquerade as AHRE.
This is exactly the kind of finding task B7 exists for: the number in the summary panel is a hypothesis, and the electrogram is the evidence.
Pacing-induced cardiomyopathy
Chronic right ventricular apical pacing produces an LBBB-like activation pattern with mechanical dyssynchrony . A patient with a new drop in ejection fraction, high RV pacing percentage, and no other explanation should be flagged for consideration of upgrade to biventricular or conduction system pacing . Prevention uses algorithms that minimize unnecessary ventricular pacing by extending the AV delay or switching between AAI and DDD modes.
Why CRT pacing percentage falls
Cause Recognition
Atrial fibrillation with rapid conduction Intrinsic conduction outpaces the device; may need rate control or AV junction ablation
- Frequent premature ventricular complexes High PVC counts in diagnostics; consider PVC ablation
- Loss of LV capture Rising LV threshold or impedance change
- Phrenic nerve stimulation forcing low output Documented diaphragmatic stimulation; reprogram the pacing vector
- Programmed AV delay too long Intrinsic conduction pre-empts the paced beat
- 3. ICD Therapy Episodes
An ICD episode report shows the detected rate, the zone entered, the discrimination decision, and the therapy delivered.
Detection zones are programmed by rate: a VT monitor zone (detect only), a VT zone (usually anti-tachycardia pacing first, then shocks), and a VF zone (shock, sometimes with ATP delivered during charging). Contemporary programming favors higher rate cut-offs and longer detection durations , because many fast rhythms terminate spontaneously and unnecessary shocks are harmful.
Anti-tachycardia pacing (ATP) delivers a burst or ramp of pacing faster than the tachycardia to penetrate the excitable gap and terminate reentrant monomorphic VT painlessly. It is effective in a large majority of monomorphic VT episodes and is attempted first whenever the rhythm permits.
Appropriate versus inappropriate therapy is the central interpretive question:
- Appropriate shock Inappropriate shock
- True VT or VF on the electrogram SVT with rapid conduction (AF, flutter, sinus tachycardia)
Rate in zone, morphology distinct from sinus, AV dissociation T-wave oversensing — alternating large/small deflections, rate exactly double the true rate
- Lead fracture / noise — non-physiologic, very short intervals; abrupt impedance rise
- Diaphragmatic myopotential oversensing — noise with deep breathing or on integrated bipolar leads
- Double counting of the R wave
Discrimination algorithms separate SVT from VT in the VT zone: onset (gradual for sinus tachycardia, abrupt for VT), stability (irregular for AF, regular for VT), morphology compared with a stored sinus template, and, in dual-chamber devices, AV relationship (more V than A events supports VT; more A than V supports atrial flutter or fibrillation). These algorithms are not applied in the VF zone , where the device shocks without discrimination — the deliberate safety trade-off.
Electrical storm is defined as three or more separate ventricular arrhythmia episodes requiring therapy within 24 hours and is a medical emergency requiring antiarrhythmic therapy, sedation, treatment of the trigger, and consideration of urgent ablation.
4. Conveying the Data
Task B7 explicitly includes conveying the information. During an active case the operator needs a short, structured, unambiguous statement rather than a printout. An effective format:
Device and dependence. "Medtronic dual-chamber ICD, implanted 2021. Patient is pacemaker-dependent, no escape below 30."
Battery and leads. "Battery normal, estimated 4 years. RV lead impedance 480 ohms and stable, threshold 0.75 volts at 0.4 milliseconds, R wave 9 millivolts. Atrial lead unchanged."
The finding that changes management. "Mode switch burden is 22 percent, with an atrial high-rate episode of 31 hours last week, confirmed on the electrogram as true atrial fibrillation."
Therapies. "Two episodes in the past month, both terminated by ATP, no shocks. Morphology consistent with monomorphic VT."
What has been changed. "Tachytherapy is now suspended and the device is programmed DOO at 70. It must be restored before the patient leaves the room."
Two communication rules apply. Never report a device-generated conclusion as fact without checking the electrogram — the correct phrasing is "the device counted 14 atrial high-rate episodes; I reviewed the electrograms and 11 are true atrial fibrillation and 3 are far-field R-wave oversensing." And always close the loop on reprogramming , because the most common device-related adverse event in a procedural setting is a device left in its procedural configuration.